Observational studyBMC musculoskeletal disorders2026
Primary shoulder arthroplasty trends in Sweden: a 16-year observational study from 2008 to 2023.
Observational study in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimaryshoulder arthroplasty is increasingly used to treat degenerative and traumatic shoulder conditions. This study aims to analyze incidence trends of primary shoulder arthroplasty in Sweden from 2008 to 2023 and to evaluate temporal changes in surgical and fixation methods, with projections for future incidence rates through 2025 and 2030.
methodsA retrospective, population-based study combining data from the Swedish National Patient Register (NPR) and the Swedish Shoulder Arthroplasty Register (SSAR). All patients aged ≥ 15 years undergoing primary shoulder arthroplasty between January 1, 2008 and December 31, 2023 were included. Incidence rates were calculated per 100,000 inhabitants, and regression modelling based on best fit were used to assess temporal trends and projections through 2030.
results28,632 primary shoulder arthroplasties were performed (women: 18,569; men: 10,063). Overall incidence increased from 13.2 to 32.7 per 100,000. Women had higher increases in absolute incidence rates (17.4 to 41.2) while men showed a greater relative increase (8.8 to 24.2). HA declined steadily, becoming the least used method. Usage of RTSA increased, becoming the most common method in individuals aged ≥ 65 years. Cemented fixation declined across both age groups.
conclusionThe incidence of primary shoulder arthroplasty in Sweden more than doubled between 2008 and 2023, with a shift towards RTSA, away from HA and cemented fixation. Projections indicate continued growth through 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.